Clinical Trial Update: Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris [Phase 3]

View source ↗

Summary

Clinical trial update noting a Phase 3 study evaluating the efficacy and safety of clascoterone cream 1% for facial acne vulgaris, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Clascoterone cream 1% (clascoterone)

Snippet

Sponsor: Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. | Conditions: Acne Vulgaris | Phase 3 | Status: RECRUITING